Stay updated on Clinical Trial of KB103 for DEB Patients
Sign up to get notified when there's something new on the Clinical Trial of KB103 for DEB Patients page.

Latest updates to the Clinical Trial of KB103 for DEB Patients page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion criteria for a clinical trial on Dystrophic Epidermolysis Bullosa (DEB), while adding a new revision number and a mention of the study's treatment assignment method.SummaryDifference29%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial of KB103 for DEB Patients
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of KB103 for DEB Patients page.